FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

JBCHEPHARM Share Price Discussion

JB Chemicals & Pharmaceuticals Ltd.
NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01028 | Sector: Pharmaceuticals and health care

JBCHEPHARM Rating

5/5 (1 Ratings)
JBCHEPHARM Share Price *
538.75 +3.8 (0.71%)
* (quote may be delayed)
Find answers to all your questions on live JBCHEPHARM message board: Is JBCHEPHARM buy or sell? Should I buy JBCHEPHARM shares? Why are JBCHEPHARM shares falling? Should I invest in JBCHEPHARM stock?

You can also check JBCHEPHARM share price target recommended by brokerages.

JBCHEPHARM Discussion Forum

@newsbot • Reputation: 2,308
Trade Setup for Thursday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 12067.1, followed by 12008.3. If the index continues moving up, key resistance levels to watch out for are 12159.7 and 12193.5.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
J B Chemicals gets EIR from USFDA for unit in Gujarat
The company has received EIR from the United States Food and Drug Administration (US FDA) for its newly set up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, J B Chemicals and Pharmaceuticals said in a regulatory filing.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
JB Chemicals share price hits record high on EIR for Panoli unit
At the end of the inspection in June 2019, no objectionable observation was found and no Form 483 was issued, JB Chemicals said.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Ranitidine recall forces GSK to alter Indian market strategy
GSK had initiated global voluntary recall of Ranitidine in September 2019, following reports of a probable cancer causing impurity called N‐nitrosodimethylamine (NDMA).
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
JB Chemicals Gujarat unit passes USFDA inspection with one observation
The company's solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, has successfully passed periodical inspection by USFDA with one minor procedural observation, JB Chemicals and Pharmaceuticals said in a filing to BSE.
Moneycontrol
Like
reply
Reply
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

Jb chemical 560(+200) 2nd target done. +50% returned upper resistance 588
✌️✌️
1
reply
Reply
@Stockstudy8 • Reputation: 1,023

Twitter
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...357.20 BUY AT 350 LVL 4 SHRTTERM....

JB CHEMICAL 35O TO 513 ♡♡
1
reply
Reply
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

*Exit book profit from jb full* almost t2
40% gained #ReturnChecque 😍
Like
reply
Reply
@TTA • Reputation: 19,789
JBCHEPHARM

Type
Buy
Instrument
JBCHEPHARM
Entry Price
₹508.35
Price@Trade
₹508.35
Target Price
₹539.9
Stop Price
₹484.9
Valid Till
Feb 20, 2020 3:20 PM
Margin
₹508.35 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹484.9
Net P&L
-4.61% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Feb 1 7:18 PM

Update
Stoploss Hit
Exit Price
₹484.9
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

JBCHEPHARM - chart - 547315
AFTER TARGET 01(130) NEXT IS 561?
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...357.20 BUY AT 350 LVL 4 SHRTTERM....

JB CHEMICAL 357 TO 473+
Like
reply
Reply
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

*Yesterday high 465* book 50% +106 *book 50%* second target still 🔛
Like
reply
Reply
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

High 455 *Full target running* near to target 01 (+96) 💘🌠💘
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL 357 TO 433 POSSIBLE 450+ SOON

J B CHEMICAL...455+
Like
reply
Reply

JBCHEPHARM - 508409
Buy J B Chemicals & Pharmaceuticals Ltd For Target Rs.550 - ANGEL BROKING LTD
National Pharmaceuticals Pricing Authority (NPPA) has notified one-time price increase of 50% from existing ceiling price in case of 21 drugs. This is in view of public interest to avoid shortage of t...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 3,135

J B Chemicals & Pharmaceuticals announces increase in price of Metronidazole formulations
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...357.20 BUY AT 350 LVL 4 SHRTTERM....

JB CHEMICAL 357 TO 433
POSSIBLE 450+ SOON
Like
reply
Reply
The Inside Guy in JBCHEPHARM
*Investment call* buy JB chemical and pharma cm...

High 434 (+80) ⚡⚡
Like
reply
Reply

💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
BUY JBCHEMICALS AT THE VERY BEGINING
STRICT STOP LOSS - 397.25
TARGET - 407/409/412
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial adv...
Read more...
Like
reply
Reply
@Stockstudy8 • Reputation: 1,023
#PotentialBreakout #SmallcapPharma #StockToWatchOut
A blog about Technical View on Equities, Commodity, Global Markets on the principles of Traditional Technical Analysis. Learn , Earn and Enjoy.
stockstudy8
2
reply
Reply

*Investment call* buy JB chemical and pharma cmp 359.80 SL 300 tgt 465-560
12 shares
Like
reply
Reply (1)
Latest replies

*Stoploss Modification* 330 (30)
@newsbot • Reputation: 2,308
ICICI Securities sees Nifty at 13,400 in next one year; L&T, NMDC among top 10 picks
ICICI Securities, in a recent note, maintained its one-year target for the Nifty at 13,400, which translates into an upside of 20 percent from current levels.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Manufacturers say Rantac safe for consumption, NDMA within permissible limits
Earlier this week on September 23, the Drug Controller General of India (DCGI) asked state regulators to direct manufacturers of Ranitidine API to take measures to verify their products for the presence of NDMA, in order to ensure safety of consumers/patients.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos
Sources within pharma industry told Moneycontrol that Dr Reddy’s and Saraca Laboratories are two big suppliers of the Ranitidine active pharmaceutical ingredient (API) globally, from which most other companies source the API to formulate the drug.
Moneycontrol
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL HIGH 383+

JB CHEMICAL HIGH 403
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...357.20 BUY AT 350 LVL 4 SHRTTERM....

JB CHEMICAL HIGH 411 HOLD ON
Like
reply
Reply

JBCHEPHARM - chart - 358183
Jbchem
Like
reply
Reply

JBCHEPHARM - chart - 358180
Jbchem
Like
reply
Reply
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...375+ ACHV SHRTTERM TARGET...❣

JB CHEMICAL HIGH 383+
2
reply
Reply (2)
Latest replies
HALAL INVESTMENT in JBCHEPHARM
JB CHEMICAL...357.20 BUY AT 350 LVL 4 SHRTTERM... PUT 345 AS CBSL 4 SHRT... EXPECT TARGET 375+ IN...

JB CHEMICAL...375+
ACHV SHRTTERM TARGET...❣
1
reply
Reply

JB CHEMICAL...357.20
BUY AT 350 LVL 4 SHRTTERM...
PUT 345 AS CBSL 4 SHRT...
EXPECT TARGET 375+ IN SHRT..
PUT 315 FOR MIDTERM STPLS..
POSSIBLY TOUCH 425/450+ IN MIDTERM...
JBCHEPHARM - chart - 239618
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@guptan • Reputation: 3,140

Jbchem
JBCHEPHARM - chart - 208988
Like
reply
Reply
@guptan • Reputation: 3,140

Buy jbchem for tgt 430 cmp 386 sl 370
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@rkg14 • Reputation: 0

Buy J B chemical and pharma buy zone 345-330 WITH SL OF 320 CB EXPECTED TGT 400
Like
reply
Reply (2)
Latest replies
Rkg @rkg14
Apr 9 3:09 AM

Coming in buy zone nw
Rkg @rkg14
May 14 3:14 PM

Sl hit

ONE CASH JACKPOT PICK FOR 5-10% UPSIDE

CAN ALSO HIT UPPER CIRCUITS
COMING UP NEXT
Like
reply
Reply
@chaudhary • Reputation: 1,895

JB Chemical Q3 reported better than street expected Q3 results. Company reported Q3 net profit Rs463.7mn (up 37% YoY) and income Rs3.52bn (up 15.5% YoY)
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
  • JBCHEPHARM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,885.79
    Enterprise Value2,891.02
    Price to Earnings20.18
    Price to Book Value1.94
    Return on Capital Employed0.12
    Return on Equity0.09
    Face Value2
    Dividend Yield0.01
  • JBCHEPHARM Share Price - Technicals

    keyboard_arrow_down
    JBCHEPHARM - 52 Week High₹599.9
    JBCHEPHARM - 52 Week Low₹308.55
  • JBCHEPHARM - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    24-May-19AnandRathiBuy455
    26-Dec-18AnandRathiBuy416
    3-Mar-17CD EquisearchAccumulate386
    14-Dec-16CD EquisearchBuy456
    JBCHEPHARM Brokerage Price Target
  • JBCHEPHARM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 19537.9553531.4534.95
    Feb 18555.9555.9523.8535.2
    Feb 17588.9588.9533.95555.9
    Feb 14578599.9578583.9
    Feb 13569.8589.95569584
  • JBCHEPHARM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹530.86
    30 Day Moving Average₹509.68
    50 Day Moving Average₹477.07
    100 Day Moving Average₹425.75
    200 Day Moving Average₹397.23
  • JBCHEPHARM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,2501,174.660.06
    Operating Profit200222.16-0.1
    Profit Before Tax179216.79-0.17
    Net Income128172.96-0.26
  • JBCHEPHARM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,4851,4540.02
    Total Liabilities308332-0.07
    Total Assets1,7921,7850
  • JBCHEPHARM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity116176.65-0.34
    Cash from Investing Activity-24-42.99-0.44
    Cash from Financing Activity-59-163.91-0.64
    Net Cash Flow32-30.25-2.06
  • JBCHEPHARM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.070.1
    Return on Equity0.090.12
    Return on Capital Employed0.120.15
  • JBCHEPHARM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.18
    3 Year CAGR Growth in Operating Profit0.04
    3 Year CAGR Growth in EBIDTA0.17
    3 Year CAGR Growth in Net Income0.13
    3 Yr CAGR Growth - Diluted EPS0.14
  • JBCHEPHARM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.53
    5 Year CAGR Growth in Operating Profit0.8
    5 Year CAGR Growth in EBIDTA0.73
    5 Year CAGR Growth in Net Income0.51
    3 Yr CAGR Growth - Diluted EPS0.53
  • JBCHEPHARM - Recent News

    keyboard_arrow_down
    NewsBot
    Yesterday 2:58 AM
    Trade Setup for Thursday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Feb 11 5:03 PM
    J B Chemicals gets EIR from USFDA for unit in Gujarat
    Moneycontrol
    NewsBot
    Feb 11 4:48 PM
    JB Chemicals share price hits record high on EIR for Panoli unit
    Moneycontrol
    NewsBot
    Feb 11 12:28 AM
    Ranitidine recall forces GSK to alter Indian market strategy
    Moneycontrol
    NewsBot
    Feb 10 4:28 PM
    JB Chemicals Gujarat unit passes USFDA inspection with one observation
    Moneycontrol
    NewsBot
    Oct 9 5:18 PM
    ICICI Securities sees Nifty at 13,400 in next one year; L&T, NMDC among top 10 picks
    Moneycontrol
    NewsBot
    Sep 30 8:48 PM
    Manufacturers say Rantac safe for consumption, NDMA within permissible limits
    Moneycontrol
    NewsBot
    Sep 26 12:28 AM
    GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos
    Moneycontrol
    NewsBot
    Jun 18 4:18 PM
    NewsBot
    May 22 1:18 PM
  • JBCHEPHARM - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.